Cynata update on the Share Café “Hidden Gems” Webinar series held on 28 August 2020
William Canty of Boardroom.Media speaks with Dr Ross Macdonald and Dr Kilian Kelly about Cynata's market position, research and clinical trials.
Listen to Stockhead’s resident Health and Biotech expert Tim Boreham discuss Cynata with CEO Dr Ross Macdonald
Here is the interview
Read an article published in BioProcess International which explores Cynata’s interest in this area.
Finance News Network discusses with Cynata CEO Dr Ross Macdonald the Company’s 1H20 results, upcoming Phase 2 clinical trials, licensing and strategy to build the company's Cymerus cell therapy platform